BIOMEA FUSION INC (BMEA:NASDAQ)

$1.17 -0.02 (-1.6807%)

watchlist-icon
search-icon
Profile Icon

Most Recent Average Sentiment Analysis Score (0 to 100): 68

negative-sentiment
Negative [0, 35)
neutral-sentiment
Neutral [35, 65]
positive-sentiment
Positive (65, 100]
Visualize Sentiment Trendline

Analysed BIOMEA FUSION INC (BMEA:NASDAQ) News Sources

Biomea Fusion Details Icovamenib Diabetes Milestones, Teases BMF-650 Obesity Readouts

30-03-2026

marketbeat.com

Biomea Fusion Announces First Patient Dosed in Newly Initiated Phase II Programs Enrolling Type 2 Diabetes Patients Failing on Standard-of-Care Therapies

31-03-2026

yahoo.com

Biomea Fusion Announces Positive 52-Week Results from Phase 2 COVALENT-112 Trial in Type 1 Diabetes Showing C-Peptide Improvement and Durability Following 12-Weeks of Icovamenib Treatment

27-04-2026

yahoo.com

Biomea Fusion Shares Early Type 1 Diabetes Data as COVALENT-112 Shows C-Peptide Gains with Icovamenib

28-04-2026

marketbeat.com

Biomea Fusion Status Update: Experts Discuss Icovamenib’s Promise Ahead of ADA 2026

05-05-2026

marketbeat.com

Biomea Fusion Announces Poster Presentations of Icovamenib at the American Diabetes Association (ADA) 86th Scientific Sessions

05-05-2026

yahoo.com

Biomea Fusion Reports First Quarter 2026 Financial Results and Corporate Highlights

11-05-2026

yahoo.com

Biomea Fusion to Participate at Upcoming Investor Conferences

12-05-2026

yahoo.com

Biomea Fusion Announces Research Collaboration with University of Leicester to Evaluate Icovamenib in Combination with Semaglutide in Obesity

03-06-2026

yahoo.com

Biomea Fusion Presents New Clinical and Translational Data for Icovamenib at the American Diabetes Association (“ADA”) 86th Scientific Sessions and Announces Expansion of Ongoing Phase I BMF-650 Study

05-06-2026

yahoo.com

BIOMEA FUSION INC (BMEA:NASDAQ) Sentiment Trend

0 25 50 75 100 36 79 50 89 32 73 79 77 84 84 30-03-2026 31-03-2026 27-04-2026 28-04-2026 05-05-2026 11-05-2026 12-05-2026 03-06-2026 05-06-2026 #1 #2 #3 #4 #5 #6 #7 #8 #9 #10 Negative < 35 Neutral 35–65 Positive > 65 View FAQ

BIOMEA FUSION INC (BMEA:NASDAQ) FAQs

toggle

What is the current price of BIOMEA FUSION INC (BMEA:NASDAQ)?

The current price of BIOMEA FUSION INC (BMEA:NASDAQ) is $1.17.


toggle

BIOMEA FUSION INC (BMEA:NASDAQ) absolute price change since previous trading day?

The absolute price change of BIOMEA FUSION INC (BMEA:NASDAQ) since the previous trading day is $-0.02.


toggle

BIOMEA FUSION INC (BMEA:NASDAQ) percentage price change since previous trading day?

The percentage price change of BIOMEA FUSION INC (BMEA:NASDAQ) since the previous trading day is -1.6807%.


toggle

What is the most recent average sentiment score for BIOMEA FUSION INC (BMEA:NASDAQ)?

The most recent average sentiment score for BIOMEA FUSION INC (BMEA:NASDAQ) is 68 out of 100.


toggle

What is the most recent average sentiment for BIOMEA FUSION INC (BMEA:NASDAQ)?

The most recent sentiment for BIOMEA FUSION INC (BMEA:NASDAQ) is .


SEC-8K** Filing Available For BIOMEA FUSION INC (BMEA:NASDAQ)

** material developments that could impact a company's financial condition or stock price.

Author: MattELab

X Icon

GitHub Icon

MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.